Trial NCT00080847

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-03031
Secondary IDs: CDR0000356049 S0349 U10CA032102

Last trial update was posted on 2013-01-07

MeSH Interventions

Cyclophosphamide Doxorubicin Liposomal doxorubicin Oblimersen Prednisone Rituximab Vincristine

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, Non-Hodgkin

Other Conditions

Contiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID